The Need for Biomarkers to Identify at-Risk Individuals

I want to get into more detail about the specifics of the study. But from the perspective of a more conservative specialist, can you explain why we need biomarkers to identify at risk groups? And the perspective here could be, okay, we don't have a therapy at the moment. So why do we need to identify these people? If then we cannot really offer anything at the present moment. So how do you see this and how do you justify the need of biomarkers at this time point? Yeah. To a certain extent, using biomarkers and at-risk individuals is forward-looking. Looking forward to a time when there's the opportunity to identify patients at the earliest stages of degener